Serum N-Telopeptide and Bone-Specific Alkaline Phosphatase Levels in Patients With Osteonecrosis of the Jaw Receiving Bisphosphonates for Bone Metastases

Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study

Alison Stopeck, Allan Lipton, Jean-Jacques Body et al. · Journal of Clinical Oncology · 2010 · 1.6K citations

Medicine, Pharmacology, Pharmacotherapy +17

Efficacy of Pamidronate in Reducing Skeletal Complications in Patients with Breast Cancer and Lytic Bone Metastases

Gabriel N. Hortobágyi, Richard L. Theriault, Lester Porter et al. · New England Journal of Medicine · 1996 · 1K citations

Medicine, Cancer Biology, Oncology +14

American Society of Clinical Oncology 2003 Update on the Role of Bisphosphonates and Bone Health Issues in Women With Breast Cancer

Bruce E. Hillner, James N. Ingle, Rowan T. Chlebowski et al. · Journal of Clinical Oncology · 2003 · 973 citations

Medicine, Oncology, Bone Metabolism +11

Long‐term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma

Lee S. Rosen, David Gordon, Mary Kaminski et al. · Cancer · 2003 · 875 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +10

Oral Bisphosphonate-Induced Osteonecrosis: Risk Factors, Prediction of Risk Using Serum CTX Testing, Prevention, and Treatment

Joseph E. Cillo, Juan J. Ulloa · Journal of Oral and Maxillofacial Surgery · 2007 · 718 citations

Dentistry, Oral Medicine, Preventive Dentistry +15